DNA
Income statement / Annual
Last year (2024), Ginkgo Bioworks Holdings, Inc.'s total revenue was $227.04 M,
a decrease of 9.71% from the previous year.
In 2024, Ginkgo Bioworks Holdings, Inc.'s net income was -$547.03 M.
See Ginkgo Bioworks Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2001
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2001 |
| Operating Revenue |
$227.04 M |
$251.46 M |
$477.71 M |
$313.84 M |
$76.66 M |
$54.18 M |
$98.29 M |
| Cost of Revenue |
$38.55 M
|
$54.01 M
|
$204.22 M
|
$129.69 M
|
$15.61 M
|
$0.00
|
$0.00
|
| Gross Profit |
$188.49 M
|
$197.45 M
|
$273.49 M
|
$184.15 M
|
$61.05 M
|
$54.18 M
|
$98.29 M
|
| Gross Profit Ratio |
0.83
|
0.79
|
0.57
|
0.59
|
0.8
|
1
|
1
|
| Research and Development Expenses |
$424.06 M
|
$580.62 M
|
$1.05 B
|
$1.15 B
|
$159.77 M
|
$96.30 M
|
$100.48 M
|
| General & Administrative Expenses |
$246.16 M
|
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
$77.39 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$246.16 M
|
$385.03 M
|
$1.43 B
|
$862.95 M
|
$38.31 M
|
$29.48 M
|
$77.39 M
|
| Other Expenses |
$78.03 M
|
$96.21 M
|
$7.63 M
|
-$1.73 M
|
$16.13 M
|
$1.57 M
|
$0.00
|
| Operating Expenses |
$748.25 M
|
$1.06 B
|
$2.48 B
|
$2.01 B
|
$198.07 M
|
$125.78 M
|
$177.87 M
|
| Cost And Expenses |
$786.80 M
|
$1.12 B
|
$2.69 B
|
$2.14 B
|
$213.68 M
|
$125.78 M
|
$177.87 M
|
| Interest Income |
$38.61 M
|
$57.22 M
|
$20.26 M
|
$837,000.00
|
$2.58 M
|
$5.76 M
|
$0.00
|
| Interest Expense |
$94,000.00
|
$93,000.00
|
$106,000.00
|
$2.37 M
|
$2.39 M
|
$2.42 M
|
$0.00
|
| Depreciation & Amortization |
$63.02 M
|
$71.55 M
|
$61.63 M
|
$29.08 M
|
$13.86 M
|
$10.76 M
|
$14.80 M
|
| EBITDA |
-$484.39 M |
-$821.29 M |
-$2.06 B |
-$1.81 B |
-$108.59 M |
-$106.66 M |
-$219.71 M |
| EBITDA Ratio |
-2.13
|
-3.27
|
-4.56
|
-5.98
|
-1.4
|
-1.5
|
-2.24
|
| Operating Income Ratio |
-2.47
|
-3.44
|
-4.62
|
-5.83
|
-1.79
|
-1.32
|
-2.39
|
| Total Other Income/Expenses Net |
$12.25 M
|
-$28.53 M
|
$87.55 M
|
-$9.66 M
|
$12.19 M
|
-$48.24 M
|
$0.00
|
| Income Before Tax |
-$547.51 M
|
-$892.94 M
|
-$2.12 B
|
-$1.84 B
|
-$124.83 M
|
-$119.84 M
|
$0.00
|
| Income Before Tax Ratio |
-2.41
|
-3.55
|
-4.44
|
-5.86
|
-1.63
|
-2.21
|
0
|
| Income Tax Expense |
-$479,000.00
|
-$71,000.00
|
-$15.03 M
|
-$1.48 M
|
$1.89 M
|
$22,000.00
|
$0.00
|
| Net Income |
-$547.03 M
|
-$892.87 M
|
-$2.10 B
|
-$1.83 B
|
-$126.61 M
|
-$119.33 M
|
$0.00
|
| Net Income Ratio |
-2.41
|
-3.55
|
-4.41
|
-5.83
|
-1.65
|
-2.2
|
0
|
| EPS |
-10.54 |
-18.37 |
-50.15 |
-53.83 |
-3.97 |
-4.15 |
0 |
| EPS Diluted |
-10.54 |
-18.4 |
-50.2 |
-55.53 |
-4 |
-4.15 |
0 |
| Weighted Average Shares Out |
$51.89 M
|
$48.53 M
|
$41.93 M
|
$32.95 M
|
$31.65 M
|
$28.73 M
|
$34.75 M
|
| Weighted Average Shares Out Diluted |
$51.89 M
|
$48.61 M
|
$42.00 M
|
$34.01 M
|
$31.87 M
|
$28.73 M
|
$34.75 M
|
| Link |
|
|
|
|
|
|
|
